Sign In
Buy VIVO
$5.74
-0.620 (-9.75%)
At Close: Jun 03, 2026
Meridian Bioscience to Participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum
12:00pm, Monday, 16'th Nov 2020
CINCINNATI, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief
Meridian Bioscience's (VIVO) CEO Jack Kenny on Q4 2020 Results - Earnings Call Transcript
01:52pm, Friday, 13'th Nov 2020
Meridian Bioscience's (VIVO) CEO Jack Kenny on Q4 2020 Results - Earnings Call Transcript
